APA (7th ed.) Citation

C, Z., J, S., L, S., W, W., X, L., J, Y., . . . S, N. (2026). In vitro and in vivo antibacterial activity of oral tebipenem in combination with novel β-lactamase inhibitors (avibactam, relebactam, vaborbactam) against KPC-producing Enterobacterales. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. https://doi.org/10.1007/s10096-026-05547-9

Chicago Style (17th ed.) Citation

C, Zou, et al. "In Vitro and in Vivo Antibacterial Activity of Oral Tebipenem in Combination with Novel β-lactamase Inhibitors (avibactam, Relebactam, Vaborbactam) Against KPC-producing Enterobacterales." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 2026. https://doi.org/10.1007/s10096-026-05547-9.

MLA (9th ed.) Citation

C, Zou, et al. "In Vitro and in Vivo Antibacterial Activity of Oral Tebipenem in Combination with Novel β-lactamase Inhibitors (avibactam, Relebactam, Vaborbactam) Against KPC-producing Enterobacterales." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 2026, https://doi.org/10.1007/s10096-026-05547-9.